Rachel Foreman never wanted to open a private practice. Now, she has founded a local support group for parents of children ...

Bestselling author Lisa Genova of Chatham has a knack for finding the most fitting professional occupations for her ...

A MAN was plunged into a psychotic episode after antibiotics for a common infection triggered terrifying ‘antibiomania’. The 66-year-old began talking incoherently, raving and thinking ...

A Cleveland Clinic psychiatrist discusses what the latest research suggests causes bipolar, what the individual experiences, ...

After five novels about neurological conditions, the Still Alice author pens an empathetic portrayal of life with mental ...

There are many journalists hiding from the stigma of mental health, addiction, or both, trying not to appear as damaged goods ...

Antipsychotic medications can help a person with bipolar disorder stabilize their moods, reduce agitation, and improve ...

Johnson & Johnson has agreed to acquire Intra-Cellular Therapies for approximately $14.6 billion, in the largest biopharma merger-and-acquisition (M&A) deal announced in two years.

New Brunswick-based Johnson & Johnson and Bedminster-based Intra-Cellular Therapies, Inc. have entered into a definitive agreement ...

Intra-Cellular recently guided to at least $5 billion in peak Caplyta sales. Intra-Cellular’s stock was trading at $127.48, up $32.61, or 34%. J&J’s stock (NYSE:JNJ) was selling for $143.39, up $1.34.

Acquisition includes CAPLYTA® (lumateperone), the first and only U.S. FDA-approved treatment for bipolar I and II depression as an adjunctive and ...

Meet Harvard-trained neuroscientist, Cape Cod writer Lisa Genova, ('Still Alice,') in East Sandwich as she explores bipolar ...